The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Biomarker panel (TheraPrint) analyzed as a predictor of response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Peter D. Beitsch
No relevant relationships to disclose
Lisette Stork
Employment or Leadership Position - Agendia
Femke De Snoo
Employment or Leadership Position - Agendia
Justine Peeters
Employment or Leadership Position - Agendia
Pat W. Whitworth
No relevant relationships to disclose